VINC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VINC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Gross Margin % is calculated as gross profit divided by its revenue. Vincerx Pharma's Gross Profit for the three months ended in Dec. 2024 was $0.00 Mil. Vincerx Pharma's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Vincerx Pharma's Gross Margin % for the quarter that ended in Dec. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.
The historical rank and industry rank for Vincerx Pharma's Gross Margin % or its related term are showing as below:
Vincerx Pharma had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vincerx Pharma was 0.00% per year.
The historical data trend for Vincerx Pharma's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vincerx Pharma Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Gross Margin % | Get a 7-Day Free Trial | - | - | - | - | - |
Vincerx Pharma Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Gross Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Vincerx Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Vincerx Pharma's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vincerx Pharma's Gross Margin % falls into.
Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)
Vincerx Pharma's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as
Gross Margin % (A: Dec. 2024 ) | = | Gross Profit (A: Dec. 2024 ) | / | Revenue (A: Dec. 2024 ) |
= | 0 | / | 0 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (0 - 0) | / | 0 | |
= | N/A % |
Vincerx Pharma's Gross Margin for the quarter that ended in Dec. 2024 is calculated as
Gross Margin % (Q: Dec. 2024 ) | = | Gross Profit (Q: Dec. 2024 ) | / | Revenue (Q: Dec. 2024 ) |
= | 0 | / | 0 | |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | (0 - 0) | / | 0 | |
= | N/A % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vincerx Pharma (NAS:VINC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vincerx Pharma had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Thank you for viewing the detailed overview of Vincerx Pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alexander A. Seelenberger | officer: Chief Financial Officer | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
Raquel E. Izumi | director, 10 percent owner, officer: Chief Operations Officer | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
Ahmed Md Hamdy | director, 10 percent owner, officer: President and CEO | 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085 |
Tom C Thomas | officer: See Remarks | 180 LOMA ALTRO, C/O MOCON INC, LOS GATOS CA 95030 |
Christopher P. Lowe | director | 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258 |
Laura I. Bushnell | director | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
Rubric Capital Management Lp | 10 percent owner | 155 EAST 44TH ST, SUITE 1630, NEW YORK NY 10017 |
David Efraim Rosen | 10 percent owner | 155 EAST 44TH ST., SUITE 1630, NEW YORK NY 10017 |
Sooin Hwang | officer: Chief Business Officer | 260 SHERIDAN AVENUE, SUITE 400, PALO ALTO CA 94306 |
Xiaoming Zhang | officer: Chief Technology Officer | 260 SHERIDAN AVE, SUITE 400, PALO ALTO CA 94306 |
Ruth E. Stevens | director | 260 SHERIDAN AVENUE, SUITE 400, PALO ALTO CA 94306 |
Garban Hermes De Jesus | officer: Chief Medical Officer | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
John C. Byrd | 10 percent owner | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
Brian Druker | director | ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
John H. Lee | director | 4500 GREAT AMERICA PKWY, STE. 100 #29, SANTA CLARA CA 95054 |
From GuruFocus
By Marketwired • 09-19-2023
By Marketwired • 12-27-2024
By Marketwired • 02-28-2025
By GlobeNewswire • 01-07-2024
By Business Wire • 12-30-2024
By Marketwired • 10-06-2023
By Business Wire • 01-06-2025
By GuruFocus Research • 03-29-2024
By Marketwired • 11-12-2024
By Marketwired • 12-04-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.